Background: Rhinosinusitis is an inflammatory disease of the nasal and paranasal sinus mucosa, and it becomes chronic when it lasts longer than 3 months without symptom improvement. The aim of this study was to determine the effect of PRP on improvement of endoscopic sinus surgery.
Introduction
Chronic rhinosinusitis (CRS) is an inflammation of the mucus that covers the nasal sinuses and the surrounding area and lasts more than 12 weeks (2) (3) (4) . Clinical signs of CRS include facial fullness, nasal congestion, postnasal discharges, rhinorrhea, hyposmia or anosmia, headache, fatigue, toothache, cough, and overpressure in the ear. In the absence of treatment, it can lead to serious complications such as periosteal cellulitis, abscess, and bowls eye (4, 5) . ______________________________ 
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In the United States, the epidemiology of sinusitis is considered parallel with the epidemiology of common colds: the incidence of colds is 2-3 and 6-8 /person/year in adults and children, respectively. Also, in the United States, bacterial sinus infection occurs in 0.5%-2% of adults and 6%-13% of children. This problem has made sinusitis one of the most common infections in patients referring to doctors. In the United States, in 2009, about 11% of adults who referred to health centers had sinusitis. Risk factors for chronic sinusitis are as follow: allergic rhinitis; asthma; nasal congestion due to polyps; foreign bodies or tumors; immune system suppression due to such diseases as agammaglobulinemia, AIDS, and chronic granulomatous disease; structural defects such as cleft palate; defects in mucocilliary system performance; and reflux (6) (7) (8) (9) .
Generally, treatment for chronic sinusitis is based on 3 principles: controlling the growth of bacteria, reducing mucosal inflammation, and reducing the flow of fluid within the sinuses. Based on existing guidelines, the main pharmacotherapeutic approaches are glucocorticosteroids and antibiotics. However, these approaches have failed many times, especially in the following cases: adult nasal polyposis, aspirin-exacerbated respiratory disease, allergic fungal rhinosinusitis, comorbid asthma, and symptomatic patients in whom maximal medical therapy has failed. Usually, in such cases, the patient should be referred to an otolaryngologist for consideration of sinus surgery (10) .
In general, the most important goals in endoscopic sinus surgery are as follow: reducing the recurrence and severity of sinus infections; improving the symptoms of sinusitis; improving the airflow through nasal passages; and enhancing the sense of smell of the patient (11) . An important challenge in CRS is the recurrence of the disease and the need for re-surgery. To avoid the recurrence of sinusitis and revision surgery, the following actions have been proposed: different antibiotics; long-time low-dose antibiotics; longtime low-dose steroids; nasal steroids; and different medications such as antiukotriene, antihistamine desensitization, vaccination, and platelet-rich plasma (PRP) (12) . PRP is concentrated blood plasma that has plentiful amounts of platelets and is provided by the patient. PRP works by degranulating the alpha granules in platelets containing a number of growth factors which can lead to early wound healing. These growth factors accelerate healing by increasing cellular proliferation, matrix formation, osteoid production, and collagen synthesis (13) . Therefore, the aim of this study was to determine the effects of PRP on improving endoscopic sinus surgery.
Methods
This was a randomized clinical trial (RCT) study designed and implemented on 21 patients with chronic rhinosinusitis in Rasool Akram hospital in Tehran during 2016-2017. The study protocol was approved by Iranian Registry of Clinical Trials (IR.IUMS.REC.1397.687). In this study, inclusion criteria for patients were bilateral chronic rhinosinusitis with polyposis, refractory to medical management, candidate for functional endoscopic sinus surgery (FESS), and age older than 18 years. The exclusion criteria also included pt. with unilateral disease, patients with platelet function disorders, thrombocytopenia and history of other comorbidities. The random number table was used to determine the PRP was used for which of the right or left sides of the nose. If the selected number of tables was paired, PRP was used for the right side of the nose, otherwise it was used for the left side.
In this study, surgery was performed in the classic manner. One side was randomly considered as the control by the researcher; and at the end of the surgery, PRP was sprayed onto the surface where the polyp was removed in the side that was intended as the case such as maxillary sinus, sphenoidal sinus, ethmoidal sinus, and frontal recess. Also, for more durability, gel like form of PRP was used. No medication therapy was done before the surgery; however, cephalexin was described for 7 days after operation.
The steps to prepare PRP was as follow: (1) 10 milliliters of patient's blood was collected; (2) 9 milliliters of blood + 1 milliliters of acid/citrate/dextrose was used as an anticoagulant; (3) blood was centrifuged 2 times at 1500 & 2000 rpm for 10 minutes; (4) 3 to 4 milliliters of PRP was provided as the supernatant with platelet concentration of about 5 times more than normal concentration; (5) Prepared PRP was used in the form of spray and gel.
The procedure was performed only once. Then, all patients were followed for 6 months and the results were documented and analyzed after 6 months. In the research, The SNOT-22 questionnaire was used for data collection. This questionnaire was completed before and after surgery intervention for patients. All items of this questionnaire are based on a scale of 0 to 5, where 0 defines no problems with the given symptom and 5 defines maximal problems. The SNOT-22 questionnaire has already been used in various studies and has been validated (14) (15) (16) .
Also, in this study, nasal endoscopy findings were graded according to Meltzer's criteria before and after surgery. Table 1 shows Meltzer scores which are used to classify nasal endoscopic findings. Polypoid sinonasal cavity was scored endoscopically from 0-4 according to degree of involvement (17) . CT findings were classified according to the Lund-Mackay. 
Results
The present study was conducted on 21 patients. The mean and standard deviation of patients' age were 36.55 and 7.91, respectively. The median Lund-McKay Pre-op CT score before treatment was 10 (9.5-11), which showed no significant difference between the 2 sides of the nose (p=0.143).
Chart 1 demonstrates the median and interquartile range (IQR) values of before and after SNOT-22 items and probability values. The items that showed statistically significant improvements after surgery were as follow: the need to blow nose, nasal blockage, sneezing, runny nose, cough, PND, thick, nasal discharge, ear fullness, facial pain/pressure, decreased sense of smell, difficulty in falling sleep, wake up at night, lack of good night sleep, wake up tired, fatigue, reduced productivity, reduced concentration, frustrated, sadness, and embarrassed (p<0.05).
Given that the results of Kolmogorov-Smirnov test showed that data did not have normal distribution, the nonparametric tests of Wilcoxon Signed Rank test (within each sides of the right and left) and Mann-Whitney U test (between the two sides of the right and left) were used to compare the Meltzer scores before and after PRP intervention. The results of Mann-Whitney U test showed that the mean of Meltzer scores in the 2 sides did not have a significant difference before and after PRP intervention (p=0.083, p=0.326, respectively). The results of the Wilcoxon Signed Rank test, which were used to compare the mean of Meltzer scores before and after PRP intervention within each of the sides, showed that the mean of Meltzer scores in each of the sides was significantly different before and after PRP intervention (p<0.05) ( Table 3 ). Chart 2 shows the mean of Meltzer scores before and after PRP intervention. Figure 1 shows a photo of the patient before and 
Discussion
Rhinosinusitis is an inflammatory disease of the sinus mucosa and nasal cavities. Chronic rhinosinusitis means that the symptoms last more than 3 months without significant improvement.
Diagnostic criteria include the presence of symptoms such as purulent nasal discharge, nasal obstruction, facial pain, pressure or fullness on frontal and maxillary sinus, hyposmia, inflammation in endoscopic examination, purulent discharge on ostium of maxillary sinus and osteomatal complex, mucosal edema of the middle meatus or ethmoidal sinus, polyps in the nasal cavity or the middle meatus, and radiographic imaging showing opacification or inflammation of the paranasal sinuses (18, 19) . Chronic rhinosinusitis is more commonly attributed to CRS with nasal polyps (CRSwNP) and CRS without nasal polyps (CRSsNP) (20) . The pathogenesis of CRS is controversial. The inflammatory process begins when bacteria, fungi, viruses, allergens, or environmental toxins interact with host environment. Defects in the normal functioning of the epithelial barriers, including the reduction of the expression of antimicrobial products, the loss of integrity of the barrier, and colonization by fungi and bacteria, have a significant effect on chronic inflammation. This chronic inflammation is characterized by increase in inflammatory cytokines and chemokine, including IL-5, thymic stromal lymphopoietin, and CCL11, which help to initiate chronic inflammatory response. Thus, gathering of immune cells, including eosinophils, mast cells, group 2 innate lymphoid cells, and lymphocytes in the chronic inflammatory response leads to nasal polyps (21) (22) (23) . To date, various treatments have been developed to improve CRS. The most effective nonsurgical treatment has been intranasal steroids and nasal saline irrigation. There are inadequate data on using oral steroid in CRS without nasal polyposis. Topical antibiotics do not show any benefit in CRS without nasal polyps. Long-term antibiotics have shown possible therapeutic response after treatment for 12 weeks; however, there is concern for development of antibiotic resistant bacteria with subsequent infections. Endoscopic sinus surgery in CRS has been shown to be safe and effective when medical treatment 5 has failed and in the patients with long-term maintenance medical therapy (24, 25) . On the other hand, after FESS, patients may experience high level of recurrence of rhinosinusitis symptoms and nasal polyposis. Therefore, to improve and reduce postsurgical recurrence rate and mucosal healing, in this study, it was aimed to use PRP because of its anti-inflammatory mechanism to decrease the number of FESS revisions and decrease resistance to antibiotics.
Platelet-rich plasma consists of multiple growth and healing factors such as platelet derived growth factor, transforming growth factor, and vascular endothelial growth factor.
These agents are released by activating platelets that can be controlled by a variety of substances or stimulants such as thrombin, calcium chloride, collagen, or adenosine 5cdiphosphat. In addition to growth factors, PRP contains fibrinogen and a number of sticky glycoproteins that support cell migration antibacterial activity by increasing the local concentration of white blood cells and antibiotic proteins, resulting in the use of products in postoperative patients as an additive to standard therapy in an effort to prevent infection.
PRP has an effective role in proliferation and differentiation of human dermal fibroblasts and myofibroblasts, which improves wound healing. Because of these properties, PRP has been used in various fields of surgery such as dental regenerative surgery, trauma, orthopedic surgery, and ophthalmology (26) (27) (28) . The effects of PRP on rhinosinusitis have been studied previously. Rice et al in 2006 designed a study to assess the healing properties of platelet-rich plasma (PRP) after endoscopic sinus surgery in 30 patients with bilateral and symmetrical chronic rhinosinusitis who did not respond to medical treatment. After 13 operations, follow-up evaluations demonstrated no benefit for using PRP, and the study was terminated early. Further research was not done until Salah El Din et al in 2012 performed a randomized single blinded study on 60 patients with inferior turbinate hypertrophy. They used PRP in one group and saline in the other group (29) . In their follow-up, nasal mucocilliary clearance was considered and the clearance of mucocilliary was improved in both groups, but it was statistically more significant in patients with PRP insertion. Due to positive effects of PRP and its anti-inflammatory properties, in this study, it was decided to reevaluate its effects on CRS patients after FESS intraoperatively.
According to SNOT-22, the most common symptoms which were reported by the patients were as follow: the need to blow nose, nasal obstruction, and postnasal discharges, which were reduced significantly 6 months after PRP was instilled. There was a significant difference in Meltzer score before and after treatment in the both treated and control sides. Overall analysis of patients' symptoms according to the scores recorded from SNOT-22 questionnaire data revealed statistically significant reduction after 6 months. This analysis showed the positive effect of both FESS and PRP. However, endoscopic grading of that side of the nasal cavity treated by PRP showed a difference; however, the reduction was nonsignificant when compared to the control side after 6 months.
Conclusion
Findings of this study suggested that treatment by PRP may be effective in reducing symptoms of patients showing recurrence of CRS symptoms following endoscopic sinus surgery subjectively but not objectively. Therefore, further studies should be conducted to obtain more accurate results on the effect of PRP on the nasal polyp. Also, taking more photos before and after the surgery and longer follow-ups can be helpful in studying polyp revision cases. The CSS group without a nasal polyp can also be considered to study PRP even in cases that are not candidates for surgery and can be checked for symptom relief. Moreover, it is better to have a longer follow-up. Also, it may be possible to improve PRP on the surgical site (not necessarily by spraying) and achieve the best effect of PRP on the nasal polyps. However, the above-mentioned will require further investigation in future studies.
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